Among these, circulating tumor DNA (ctDNA) has emerged as a minimally invasive biomarker for monitoring therapeutic response and detecting minimal residual disease [136]
Customised design of antisense oligonucleotides targeting EGFR driver mutants for personalised treatment of non-small cell lung cancer
J Pineal Res (2012) 52(3):28290
Your review * Cant wait to be able to get this I want this ASAP
Studying these metabolic processes builds upon a well-mapped understanding of cancer metabolism, which, in concert with existing and newly developed therapies, can make an immense difference in a cancer patients course of treatment
Reported benefits often appear anecdotal, influenced by concurrent skincare routines, sun protection, diet, and placebo effect